DaVita Inc. (NYSE:DVA) Shares Sold by Texas Permanent School Fund Corp

Texas Permanent School Fund Corp reduced its holdings in DaVita Inc. (NYSE:DVA) by 26.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,209 shares of the company’s stock after selling 2,924 shares during the quarter. Texas Permanent School Fund Corp’s holdings in DaVita were worth $1,138,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of DVA. 8 Knots Management LLC acquired a new stake in shares of DaVita in the 4th quarter valued at approximately $89,504,000. Doma Perpetual Capital Management LLC acquired a new stake in shares of DaVita in the 4th quarter valued at approximately $53,076,000. Norges Bank acquired a new stake in shares of DaVita in the 4th quarter valued at approximately $36,626,000. Allianz Asset Management GmbH lifted its holdings in shares of DaVita by 63.9% in the 4th quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock valued at $57,476,000 after buying an additional 213,992 shares during the period. Finally, Pinebridge Investments L.P. lifted its holdings in shares of DaVita by 148.8% in the 4th quarter. Pinebridge Investments L.P. now owns 268,601 shares of the company’s stock valued at $28,139,000 after buying an additional 160,630 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Insider Activity at DaVita

In related news, insider Kathleen Alyce Waters sold 7,857 shares of DaVita stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the transaction, the insider now owns 83,011 shares in the company, valued at $12,137,038.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, COO Michael David Staffieri sold 9,539 shares of DaVita stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares of the company’s stock, valued at $36,299,008.35. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Kathleen Alyce Waters sold 7,857 shares of DaVita stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total value of $1,148,771.97. Following the sale, the insider now directly owns 83,011 shares in the company, valued at $12,137,038.31. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 173,482 shares of company stock worth $27,387,069. 2.00% of the stock is owned by insiders.

Analyst Ratings Changes

Several research firms have recently commented on DVA. Truist Financial raised their price target on DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a report on Tuesday, August 20th. Bank of America raised their price objective on DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a research note on Wednesday, August 7th. StockNews.com downgraded DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. UBS Group raised their price objective on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a research note on Thursday, August 8th. Finally, TD Cowen raised their price objective on DaVita from $139.00 to $150.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $157.00.

DaVita Price Performance

Shares of NYSE:DVA opened at $164.00 on Friday. The company has a market cap of $14.38 billion, a P/E ratio of 18.64, a P/E/G ratio of 0.95 and a beta of 0.87. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94. DaVita Inc. has a 52 week low of $71.51 and a 52 week high of $166.04. The business has a fifty day simple moving average of $147.19 and a 200-day simple moving average of $140.85.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $2.59 EPS for the quarter, beating analysts’ consensus estimates of $2.47 by $0.12. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.15 billion. DaVita had a return on equity of 77.00% and a net margin of 6.86%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.08 earnings per share. Equities research analysts forecast that DaVita Inc. will post 9.99 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.